Atlanta Biotech Company Participates in International Stroke Conference

Company with proprietary stroke precursor assays continues scientific and public outreach.

Atlanta, GA (PRWEB) January 25, 2006 -- CIS Biotech, Inc., the 5-year old Georgia company that is bringing stroke risk assessment tests to the market, will be an exhibitor and presenter at the 2006 International Stroke Conference that will be held February 16-18 in Kissimmee, Florida.

“CIS has been participating in international conferences and trade shows for several years now”, said the company’s Chairman and CEO, Robert Rhinehart, “most recently in Düseldorf, Germany, and we plan to continue building on the successes we have already achieved.” Citing a recent collaboration with DeKalb Medical Center and a partnership with the Diagnostics Division of Bayer Healthcare, coupled with greater recognition in the professional media, Rhinehart believes the company’s position as the market’s premier provider of simple, inexpensive blood tests for stroke risks continues to strengthen. “Being visible in and contributing to the scientific community is an important aspect of our growth path”, he asserts.

In addition to exhibiting CIS Biotech’s products at the Florida conference, the Chair of its Board of Scientific Advisors, Professor Svetlana Dambinova, researcher and discoverer of new brain biomarkers for stroke, will deliver a poster presentation.

CIS Biotech provides information about stroke, blood tests, and diagnostic tools on its web site, www.cisbiotech.com. The stroke test is currently available for research purposes only. Information about the 2006 International Stroke Conference may be accessed at http://strokeconference.americanheart.org/portal/strokeconference/sc/

# # #